Nisa Investment Advisors LLC increased its stake in shares of American Well Co. (NYSE:AMWL – Get Rating) by 440.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,100 shares of the company’s stock after acquiring an additional 6,600 shares during the quarter. Nisa Investment Advisors LLC’s holdings in American Well were worth $34,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also bought and sold shares of the company. Gagnon Securities LLC bought a new stake in shares of American Well during the fourth quarter valued at approximately $62,000. Gagnon Advisors LLC bought a new stake in shares of American Well in the fourth quarter worth $64,000. State Board of Administration of Florida Retirement System grew its holdings in shares of American Well by 10.7% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 58,394 shares of the company’s stock worth $353,000 after acquiring an additional 5,656 shares during the period. Vigilant Capital Management LLC bought a new stake in American Well during the first quarter valued at about $42,000. Finally, CIBC Asset Management Inc bought a new stake in American Well during the fourth quarter valued at about $62,000. 43.75% of the stock is currently owned by institutional investors.
Insider Transactions at American Well
In other news, CEO Ido Schoenberg sold 300,000 shares of the company’s stock in a transaction on Friday, July 1st. The stock was sold at an average price of $4.39, for a total transaction of $1,317,000.00. Following the sale, the chief executive officer now owns 2,073,108 shares of the company’s stock, valued at $9,100,944.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Ido Schoenberg sold 300,000 shares of the stock in a transaction on Friday, July 1st. The stock was sold at an average price of $4.39, for a total value of $1,317,000.00. Following the transaction, the chief executive officer now owns 2,073,108 shares of the company’s stock, valued at $9,100,944.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Robert Shepardson sold 24,986 shares of the stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $3.57, for a total value of $89,200.02. Following the completion of the transaction, the chief financial officer now directly owns 963,289 shares in the company, valued at approximately $3,438,941.73. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 570,761 shares of company stock valued at $2,475,666. 14.68% of the stock is currently owned by company insiders.
Analyst Ratings Changes
American Well Stock Down 6.7 %
Shares of NYSE AMWL opened at $3.90 on Monday. American Well Co. has a 52-week low of $2.52 and a 52-week high of $11.89. The business’s 50 day moving average is $4.27 and its two-hundred day moving average is $3.98. The firm has a market cap of $1.04 billion, a price-to-earnings ratio of -4.94 and a beta of 0.22.
American Well (NYSE:AMWL – Get Rating) last posted its quarterly earnings data on Monday, May 9th. The company reported ($0.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.04). American Well had a negative return on equity of 16.72% and a negative net margin of 79.91%. The company had revenue of $64.20 million for the quarter, compared to analysts’ expectations of $64.94 million. During the same period in the prior year, the company posted ($0.16) EPS. The firm’s revenue was up 11.5% compared to the same quarter last year. Analysts anticipate that American Well Co. will post -0.98 EPS for the current fiscal year.
American Well Company Profile
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- Use These To Find Your Stock’s Support and Resistance Levels
- Is Boeing Stock is Ready for Lift-Off ?
- Elon Musk is Out, But Should You Be In Twitter Stock?
- 3 Earnings Announcements That Could Surprise
- Twitter’s Up For Third Week In A Row: What’s Next For The Stock?
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.